| Gene symbol | GUCY2C | Synonyms | DIAR6, GC-C, GCC, GUC2C, HSER, MECIL, MUCIL, STAR | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p12.3 | dbXrefs | |
| Description | guanylate cyclase 2C | ||||
| GTO ID | GTC3710 |
| Trial ID | NCT06197178 |
| Disease | Gastrointestinal Tumor |
| Altered gene | GCC |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LCAR-G08 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase 1, Open-Label Study Evaluating the Safety, Tolerability and Efficacy of (LCAR)-G08, a Chimeric Antigen Receptor (CAR)-T Cell Therapy Targeting Guanylyl Cyclase C (GCC) in Subjects With Advanced Gastrointestinal Tumors |
| Year | 2024 |
| Country | China |
| Company sponsor | Peking University |
| Other ID(s) | LB2301-0001 |
| Cohort 1 | |||||||||
|
|||||||||